Abstract
Background: Written asthma action plans based on personal best peak expiratory flow (PEF) consistently improve health outcomes, whereas those based on predicted PEF do not. Guidelines state that personal best PEF should be assessed over 2–3 weeks during good asthma control, but it is unclear how long to wait after commencing or changing treatment.
Methods: Electronically recorded spirometric data from 61 subjects with initially poorly controlled asthma from a 72 week budesonide study were analysed. For each week, average morning pre-bronchodilator PEF was calculated and personal best PEF was determined as the highest PEF in the previous 2 weeks. The time to plateau was defined as the week beyond which no further improvement occurred.
Results: At baseline, average morning PEF was 61% predicted and personal best PEF was 87% predicted. Personal best PEF from twice daily monitoring increased to a plateau of 95% predicted (p<0.0001) after only 3 weeks of budesonide treatment. However, average morning PEF continued to improve for 3 months and "as needed" reliever use for 7 months.
Conclusions: Personal best PEF is a useful concept for asthma self-management plans when determined as the highest PEF over the previous 2 weeks. With twice daily monitoring, personal best PEF reaches plateau levels after only a few weeks of corticosteroid treatment.
Full Text
The Full Text of this article is available as a PDF (83.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Diner B., Brenner B., Camargo C. A., Jr Inaccuracy of "personal best" peak expiratory flow rate reported by inner-city patients with acute asthma. J Asthma. 2001 Apr;38(2):127–132. doi: 10.1081/jas-100000030. [DOI] [PubMed] [Google Scholar]
- Donovan J. L., Blake D. R. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992 Mar;34(5):507–513. doi: 10.1016/0277-9536(92)90206-6. [DOI] [PubMed] [Google Scholar]
- Gibson P. G., Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax. 2004 Feb;59(2):94–99. doi: 10.1136/thorax.2003.011858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greening A. P., Ind P. W., Northfield M., Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet. 1994 Jul 23;344(8917):219–224. doi: 10.1016/s0140-6736(94)92996-3. [DOI] [PubMed] [Google Scholar]
- Nunn A. J., Gregg I. New regression equations for predicting peak expiratory flow in adults. BMJ. 1989 Apr 22;298(6680):1068–1070. doi: 10.1136/bmj.298.6680.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Phillips K., Oborne J., Lewis S., Harrison T. W., Tattersfield A. E. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax. 2004 Jan;59(1):26–30. doi: 10.1136/thx.2003.015297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reddel H. K., Jenkins C. R., Marks G. B., Ware S. I., Xuan W., Salome C. M., Badcock C. A., Woolcock A. J. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J. 2000 Aug;16(2):226–235. doi: 10.1034/j.1399-3003.2000.16b08.x. [DOI] [PubMed] [Google Scholar]
- Reddel H. K., Ware S. I., Salome C. M., Jenkins C. R., Woolcock A. J. Pitfalls in processing home electronic spirometric data in asthma. Eur Respir J. 1998 Oct;12(4):853–858. doi: 10.1183/09031936.98.12040853. [DOI] [PubMed] [Google Scholar]
- Reddel H., Ware S., Marks G., Salome C., Jenkins C., Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet. 1999 Jan 30;353(9150):364–369. doi: 10.1016/S0140-6736(98)06128-5. [DOI] [PubMed] [Google Scholar]
- Wilson David H., Adams Robert J., Appleton Sarah L., Hugo Graeme, Wilkinson David, Hiller Janet, Ryan Philip, Cheek Julianne, Ruffin Richard E. Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990 to 2001. Med J Aust. 2003 May 19;178(10):483–485. doi: 10.5694/j.1326-5377.2003.tb05320.x. [DOI] [PubMed] [Google Scholar]